Literature DB >> 26369971

Acinetobacter baumannii Extracellular OXA-58 Is Primarily and Selectively Released via Outer Membrane Vesicles after Sec-Dependent Periplasmic Translocation.

Yu-Ting Liao1, Shu-Chen Kuo2, Ming-Hsien Chiang3, Yi-Tzu Lee4, Wang-Chou Sung5, You-Hsuan Chen5, Te-Li Chen6, Chang-Phone Fung7.   

Abstract

Carbapenem-resistant Acinetobacter baumannii (CRAb) shelter cohabiting carbapenem-susceptible bacteria from carbapenem killing via extracellular release of carbapenem-hydrolyzing class D β-lactamases, including OXA-58. However, the mechanism of the extracellular release of OXA-58 has not been elucidated. In silico analysis predicted OXA-58 to be translocated to the periplasm via the Sec system. Using cell fractionation and Western blotting, OXA-58 with the signal peptide and C terminus deleted was not detected in the periplasmic and extracellular fractions. Overexpression of enhanced green fluorescent protein fused to the OXA-58 signal peptide led to its periplasmic translocation but not extracellular release, suggesting that OXA-58 is selectively released. The majority of the extracellular OXA-58 was associated with outer membrane vesicles (OMVs). The OMV-associated OXA-58 was detected only in a strain overexpressing OXA-58. The presence of OXA-58 in OMVs was confirmed by a carbapenem inactivation bioassay, proteomic analysis, and transmission electron microscopy. Imipenem treatment increased OMV formation and caused cell lysis, resulting in an increase in the OMV-associated and OMV-independent release of extracellular OXA-58. OMV-independent OXA-58 hydrolyzed nitrocefin more rapidly than OMV-associated OXA-58 but was more susceptible to proteinase K degradation. Rose bengal, an SecA inhibitor, inhibited the periplasmic translocation and OMV-associated release of OXA-58 and abolished the sheltering effect of CRAb. This study demonstrated that the majority of the extracellular OXA-58 is selectively released via OMVs after Sec-dependent periplasmic translocation. Addition of imipenem increased both OMV-associated and OMV-independent OXA-58, which may have different biological roles. SecA inhibitor could abolish the carbapenem-sheltering effect of CRAb.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26369971      PMCID: PMC4649246          DOI: 10.1128/AAC.01343-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  44 in total

Review 1.  Sec- and Tat-mediated protein secretion across the bacterial cytoplasmic membrane--distinct translocases and mechanisms.

Authors:  Paolo Natale; Thomas Brüser; Arnold J M Driessen
Journal:  Biochim Biophys Acta       Date:  2007-08-09

Review 2.  Bacterial protein secretion through the translocase nanomachine.

Authors:  Effrosyni Papanikou; Spyridoula Karamanou; Anastassios Economou
Journal:  Nat Rev Microbiol       Date:  2007-11       Impact factor: 60.633

3.  Secretion of bacteriolytic endopeptidase L5 of Lysobacter sp. XL1 into the medium by means of outer membrane vesicles.

Authors:  Natalia V Vasilyeva; Irina M Tsfasman; Natalia E Suzina; Olga A Stepnaya; Igor S Kulaev
Journal:  FEBS J       Date:  2008-06-28       Impact factor: 5.542

Review 4.  Proteomics in gram-negative bacterial outer membrane vesicles.

Authors:  Eun-Young Lee; Dong-Sic Choi; Kwang-Pyo Kim; Yong Song Gho
Journal:  Mass Spectrom Rev       Date:  2008 Nov-Dec       Impact factor: 10.946

5.  Sec- and Tat-dependent translocation of beta-lactamases across the Escherichia coli inner membrane.

Authors:  N Pradel; J Delmas; L F Wu; C L Santini; R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2008-11-03       Impact factor: 5.191

6.  Ultrastructural localization of an extracellular protease in Pseudomonas fragi by using the peroxidase-antiperoxidase reaction.

Authors:  S S Thompson; Y M Naidu; J J Pestka
Journal:  Appl Environ Microbiol       Date:  1985-10       Impact factor: 4.792

7.  Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii.

Authors:  Te-Li Chen; Roy Chen-Chih Wu; Men-Fang Shaio; Chang-Phone Fung; Wen-Long Cho
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

8.  Biogenesis of bacterial membrane vesicles.

Authors:  Brooke L Deatherage; J Cano Lara; Tessa Bergsbaken; Sara L Rassoulian Barrett; Stephanie Lara; Brad T Cookson
Journal:  Mol Microbiol       Date:  2009-05-08       Impact factor: 3.501

9.  Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.

Authors:  Nan-Yao Lee; Hsin-Chun Lee; Nai-Ying Ko; Chia-Ming Chang; Hsin-I Shih; Chi-Jung Wu; Wen-Chien Ko
Journal:  Infect Control Hosp Epidemiol       Date:  2007-05-14       Impact factor: 3.254

10.  Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate.

Authors:  Sang-Oh Kwon; Yong Song Gho; Je Chul Lee; Seung Il Kim
Journal:  FEMS Microbiol Lett       Date:  2009-06-03       Impact factor: 2.742

View more
  20 in total

Review 1.  The Secrets of Acinetobacter Secretion.

Authors:  Brent S Weber; Rachel L Kinsella; Christian M Harding; Mario F Feldman
Journal:  Trends Microbiol       Date:  2017-02-16       Impact factor: 17.079

Review 2.  Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond.

Authors:  Brent S Weber; Christian M Harding; Mario F Feldman
Journal:  J Bacteriol       Date:  2015-12-28       Impact factor: 3.490

Review 3.  Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy.

Authors:  Bora Shin; Woojun Park
Journal:  J Microbiol       Date:  2017-10-27       Impact factor: 3.422

4.  Specific Protein-Membrane Interactions Promote Packaging of Metallo-β-Lactamases into Outer Membrane Vesicles.

Authors:  Carolina López; Alessio Prunotto; Guillermo Bahr; Robert A Bonomo; Lisandro J González; Matteo Dal Peraro; Alejandro J Vila
Journal:  Antimicrob Agents Chemother       Date:  2021-07-26       Impact factor: 5.191

5.  Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology.

Authors:  Zhaohui Ni; Yan Chen; Edison Ong; Yongqun He
Journal:  Int J Mol Sci       Date:  2017-02-21       Impact factor: 5.923

6.  Antibiotic Capture by Bacterial Lipocalins Uncovers an Extracellular Mechanism of Intrinsic Antibiotic Resistance.

Authors:  Omar M El-Halfawy; Javier Klett; Rebecca J Ingram; Slade A Loutet; Michael E P Murphy; Sonsoles Martín-Santamaría; Miguel A Valvano
Journal:  mBio       Date:  2017-03-14       Impact factor: 7.867

Review 7.  Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options.

Authors:  Chang-Ro Lee; Jung Hun Lee; Moonhee Park; Kwang Seung Park; Il Kwon Bae; Young Bae Kim; Chang-Jun Cha; Byeong Chul Jeong; Sang Hee Lee
Journal:  Front Cell Infect Microbiol       Date:  2017-03-13       Impact factor: 5.293

8.  Carboxy-Terminal Processing Protease Controls Production of Outer Membrane Vesicles and Biofilm in Acinetobacter baumannii.

Authors:  Rakesh Roy; Ren-In You; Chan-Hua Chang; Chiou-Ying Yang; Nien-Tsung Lin
Journal:  Microorganisms       Date:  2021-06-20

Review 9.  Insights on the Horizontal Gene Transfer of Carbapenemase Determinants in the Opportunistic Pathogen Acinetobacter baumannii.

Authors:  Gabriela Jorge Da Silva; Sara Domingues
Journal:  Microorganisms       Date:  2016-08-23

Review 10.  Acinetobacter: an emerging pathogen with a versatile secretome.

Authors:  Noha M Elhosseiny; Ahmed S Attia
Journal:  Emerg Microbes Infect       Date:  2018-03-21       Impact factor: 7.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.